arginine has been researched along with probucol in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Bolaffi, JL; Grodsky, GM; Rodd, GG; Wang, J | 1 |
| Deng, HW; Jiang, JL; Li Ns, NS; Li, YJ | 1 |
| Egashira, K; Ohtani, K | 1 |
| Espey, MG; Harvey-White, J; Jung, CS; Oldfield, EH; Pluta, RM; Shilad, S; Whitehead, A | 1 |
| Deng, HW; Hu, CP; Jiang, JL; Li, NS; Li, YJ; Rang, WQ; Zhang, XH | 1 |
| Li, X; Ma, JP; Wang, CX; Wang, L; Wu, CJ; Xia, XS | 1 |
| Chang, H; Gao, G; Jin, B; Ma, J; Ma, P; Zhao, S | 1 |
| Fu, Q; Hu, LL; Tian, T; Zhang, H; Zhang, KQ | 1 |
| Li, Y; Liu, DF; Mei, X; Qiu, P; Tang, MW; Yang, HL; Zeng, J; Zhao, Y | 1 |
1 review(s) available for arginine and probucol
| Article | Year |
|---|---|
[NO and atherosclerosis].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Arginine; Arteriosclerosis; Endothelium, Vascular; Enzyme Inhibitors; Genetic Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Probucol; Risk Factors; Stress, Mechanical | 2004 |
1 trial(s) available for arginine and probucol
| Article | Year |
|---|---|
[Impact of adding folic acid, vitamin B(12) and probucol to standard antihypertensive medication on plasma homocysteine and asymmetric dimethylarginine levels of essential hypertension patients].
Topics: Aged; Antihypertensive Agents; Arginine; Female; Folic Acid; Homocysteine; Humans; Hypertension; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase Type III; Plasma; Probucol; Vitamin B 12; Vitamin B Complex; Vitamins | 2012 |
10 other study(ies) available for arginine and probucol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Interrelationship of changes in islet nicotine adeninedinucleotide, insulin secretion, and cell viability induced by interleukin-1 beta.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Arginine Vasopressin; beta-Endorphin; Cell Survival; Cells, Cultured; Colforsin; Corticosterone; Dynorphins; Glucose; Insulin; Insulin Secretion; Interleukin-1; Islets of Langerhans; Kinetics; Male; NAD; Niacinamide; Nitric Oxide Synthase; omega-N-Methylarginine; Probucol; Progesterone; Rats; Vitamin E | 1994 |
Probucol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level.
Topics: Animals; Aorta, Thoracic; Arginine; Endothelium, Vascular; Enzyme Inhibitors; Lipoproteins, LDL; Male; Malondialdehyde; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Probucol; Rats; Rats, Sprague-Dawley; Vasodilation | 2002 |
In vitro and in vivo effects of probucol on hydrolysis of asymmetric dimethyl L-arginine and vasospasm in primates.
Topics: Animals; Antioxidants; Arginine; Bilirubin; Cell Culture Techniques; Double-Blind Method; Endothelial Cells; Enzyme Inhibitors; Hydrolysis; Lipid Peroxidation; Macaca fascicularis; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxidation-Reduction; Placebos; Probucol; Random Allocation; Subarachnoid Hemorrhage; Time Factors; Umbilical Veins; Vasospasm, Intracranial | 2005 |
Probucol decreases asymmetrical dimethylarginine level by alternation of protein arginine methyltransferase I and dimethylarginine dimethylaminohydrolase activity.
Topics: Amidohydrolases; Antioxidants; Arginine; Cell Line; Endothelial Cells; Humans; L-Lactate Dehydrogenase; Lipoproteins, LDL; Malondialdehyde; Nitric Oxide; Nitric Oxide Synthase Type III; Probucol; Protein-Arginine N-Methyltransferases | 2006 |
Probucol Protects Against Asymmetric Dimethylarginine-Induced Apoptosis in the Cultured Human Brain Microvascular Endothelial Cells.
Topics: Antioxidants; Apoptosis; Arginine; Brain; Cells, Cultured; Endothelial Cells; Endothelium, Vascular; Humans; MAP Kinase Kinase 4; Microvessels; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Probucol | 2015 |
Probucol improves erectile function via Activation of Nrf2 and coordinates the HO-1 / DDAH / PPAR-γ/ eNOS pathways in streptozotocin-induced diabetic rats.
Topics: Amidohydrolases; Animals; Arginine; Blood Glucose; Body Weight; Cyclic GMP; Diabetes Mellitus, Experimental; Erectile Dysfunction; Heme Oxygenase-1; Male; Malondialdehyde; NF-E2-Related Factor 2; Nitric Oxide Synthase Type III; PPAR gamma; Probucol; Rats, Sprague-Dawley; Signal Transduction; Streptozocin; Superoxide Dismutase | 2018 |
Abnormalities of the PRMT1-ADMA-DDAH1 metabolism axis and probucol treatment in diabetic patients and diabetic rats.
Topics: Amidohydrolases; Animals; Arginine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Humans; Nitric Oxide; Probucol; Protein-Arginine N-Methyltransferases; Rats; Repressor Proteins | 2021 |